undamentalytics Newsletter

Cerenome, Inc. revenue

Cerenome, Inc.'s revenue was $5.2m in fiscal 2025, down 10.5% on the year before. Since fiscal 2009 ($5.8m) it has grown at a compound -0.9% a year. Over the last twelve months it was $4.2m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cerenome, Inc.: revenue history, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue5,8378,2547,9838,7097,1224,9534,8384,6562,6893,6714,9135,8245,2134,203
Growth on the year before—+41.4%−3.3%+9.1%−18.2%−30.5%−2.3%−3.8%−42.2%+36.5%+33.8%+18.5%−10.5%—
Gross profit2,4434,3464,1464,7093,7012,0131,6521,9411462,523————
Gross margin41.9%52.7%51.9%54.1%52.0%40.6%34.1%41.7%5.4%68.7%————

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Cerenome, Inc. $4.2m -21.0% 16.1%
Intelligent BIO Solutions Inc. $4.2m 38.1% 39.0%
Biomerica Inc $4.3m -11.2% -7.1%
Charming Medical Ltd $4.8m -22.7% —
Icecure Medical Ltd. $3.4m 2.7% —
Neuraxis, Inc $5.3m 65.2% 25.6%

Compare with peers

Head to head: CNSY vs INBSBMRA vs CNSYCNSY vs MCTACNSY vs ICCM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cerenome, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cerenome, Inc.